StockData
Abivax S.A. logo

Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$82.10−1.51 (-1.81%)

Close on Nov 17, 2026Market cap $6.45BP/E –Yield –

Abivax revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Abivax

Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Abivax figures

See a number that looks wrong?